Isodiol International Inc., a global CBD innovator and market leader, announces its retail division, KURE , will begin its first phase of expansion on the west coast with the opening of seven locations in the Greater Phoenix market which are anticipated to grand open in the middle of September.

The Company anticipates opening a total of ten retail locations within the Greater Phoenix market before this year’s holiday season. KURE retail locations average $900,000 per location annually.  Each new location will have a CBD section and hemp beverage section incorporated in to the floorplan to market and sell Isodiol products, including the new kathy ireland Health & Wellness  product line.

“The new locations will offer the unique Kure experience to belly up to the juice bar and test KURE On Tap flavors or have a Kurator create your own flavor experience. With the expansion of our CBD product offerings and hemp beverage selections we are confident the unique tailored experience will be a real hit in the Greater Phoenix market,” said KURE CEO, Craig Brewer. 

“KURE currently operates 11 stores in North Carolina, South Carolina and Connecticut .  The expansion of stores in the Greater Phoenix area is a strategic move for the Company to open the west coast market because of the close proximity to the Company’s vape manufacturing facility, Bradley’s Biosciences in Gilbert, AZ, ” said Isodiol International, Inc. CEO, Marcos Agramont. 

The KURE management team is continuing to work on the rollout plan for the new KURE Vape Pods which was previously announced. To learn more about the KURE Vape Pods visit KURE VAPE Pod.

 The expansion includes four Valor Vapor locations and three Evapeology locations. Renovations of each location will begin shortly to rebrand the stores to Kure and the Company anticipates to have all renovations completed in the beginning of September for a mid September official grand opening of the Greater Phoenix Market.

The expansion costs for the acquisition of the 7 stores will be $300,000 and there will be no issuance of any Isodiol securities.

For more information on Isodiol, visit